Holen Sie sich die Stockscreener-App
32.15
0.74%
-0.24
Handel nachbörslich:
32.16
0.010
+0.03%
Corcept Therapeutics Inc Aktie (CORT) Neueste Nachrichten
Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock DeclineInvestors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC – Company AnnouncementFT.com - Financial Times
A Look At Corcept Therapeutics (CORT) Valuation After Mixed Q4 And 2025 Results With Stronger 2026 Outlook - simplywall.st
CORT ALERT: Hagens Berman Alerts Corcept Therapeutics - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges Corcept Therapeutics Incorporated Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
Corcept Therapeutics (CORT) Litigation: Hagens Berman Alerts Corcept (CORT) Investors to Securities Class Action and April 21 Lead Plaintiff Deadline - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Corcept Therapeutics Incorporated of Class Action Lawsuit and Upcoming DeadlinesCORT - PR Newswire
Portnoy Law Firm Announces Class Action on Behalf of Corcept Therapeutics Incorporated Investors - GlobeNewswire
Corcept Therapeutics Lawsuit: CORT Investors Face Losses After FDA Rejection and Alleged Misleading Statements - TipRanks
CORCEPT THERAPEUTICS INCORPORATED (CORT) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds ... - Bluefield Daily Telegraph
CORCEPT THERAPEUTICS INCORPORATED (CORT) SHAREHOLDER ALERT - GlobeNewswire
CORT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Corcept Therapeutics Incorporated Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
Lawsuit filed for Investors who lost money with shares of Corcept Therapeutics Incorporated (NASDAQ: CORT) - openPR.com
Corcept Therapeutics Shareholder Alert: ClaimsFiler Reminds - GlobeNewswire
Corcept Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Corcept Therapeutics Incorporated - GlobeNewswire Inc.
ROSEN, A LEADING NATIONAL FIRM, Encourages Corcept Therapeutics Incorporated to Secure Counsel ... - Bluefield Daily Telegraph
H.C. Wainwright Cuts Corcept Therapeutics Incorporated (CORT) Price Target, Keeps Buy Rating - Yahoo Finance
Corcept Therapeutics Shareholders Are Encouraged to Contact Johnson Fistel for More Information About Potentially Recovering Their Losses - marketscreener.com
Deadline Alert: Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit - GlobeNewswire
CORT LAWSUIT ALERT: Levi & Korsinsky Notifies Corcept Therapeutics Incorporated Investors of a Class Action Lawsuit and Upcoming Deadline - Morningstar
CORT LAWSUIT ALERT: Levi & Korsinsky Notifies Corcept Therapeuti - GuruFocus
CORCEPT THERAPEUTICS INCORPORATED (CORT) DEADLINE ALERT Bernstein Liebhard LLP Reminds Corcept Therapeutics Incorporated Investors of Upcoming Deadline - ACCESS Newswire
First Trust Advisors LP Purchases 183,038 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat
CORT Investors Have Opportunity to Lead Corcept Therapeutics Inc - GuruFocus
Corcept Therapeutics Incorporated Securities Fraud Class - GlobeNewswire
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit - ChartMill
Bragar Eagel & Squire, P.C. Urges Navan and Corcept Investors with Large Losses to Contact ... - Bluefield Daily Telegraph
Bragar Eagel & Squire, P.C. Urges Navan and Corcept Investors with Large Losses to Contact the Firm Before the Upcoming Lead Plaintiff Deadlines - marketscreener.com
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire
REMINDER: Corcept Therapeutics Incorporated Investors With Significant Losses Must Act By April 21, 2026 - Business Wire
CORT STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Corcept Therapeutics Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Corcept Therapeutics Incorporated of Class Action Lawsuit and Upcoming Deadlines – CORT - ChartMill
Corcept Therapeutics (CORT) Litigation: Hagens Berman Alerts Corcept (CORT) Investors to Securities Class Action and April 21 Lead Plaintiff Deadline – Company AnnouncementFT.com - Financial Times
Relacorilant safe, works to control high blood pressure in Cushing’s: Study - Cushing's Disease News
Bronstein, Gewirtz & Grossman LLC Urges Corcept - GlobeNewswire
Important Notice to Long-Term Shareholders of Boston - GlobeNewswire
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 21, 2026 in Corcept Therapeutics Incorporated LawsuitCORT - PR Newswire
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Dimensional Fund Advisors LP Reduces Holdings in Corcept Therapeutics Incorporated $CORT - MarketBeat
Contact Levi & Korsinsky by April 21, 2026 Deadline to Join - GlobeNewswire
Hagens Berman Alerts Corcept Therapeutics (CORT) Investors - GlobeNewswire
Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit – Company AnnouncementFT.com - Financial Times
Kaplan Fox Alerts Investors to a Deadline for a Securities Fraud Class Action Lawsuit against Corcept Therapeutics, Inc. (NASDAQ: CORT)Contact Kaplan Fox Before April 21, 2026 - NewMediaWire
User - The Chronicle-Journal
CORT INVESTOR REMINDER: Corcept Therapeutics Incorporated Investors Have Until April 21, 2026 To Seek Lead Plaintiff Role - ACCESS Newswire
CORCEPT THERAPEUTICS CLASS ACTION DEADLINE: Kaplan Fox Encourages Corcept Therapeutics, Inc. (NASDAQ: CORT) Investors to Contact the Firm Before the Lead Plaintiff Deadline on April 21, 2026 - NewMediaWire
Class Action Filed Against Corcept Therapeutics - GlobeNewswire
Corcept Therapeutics (CORT) Litigation: Hagens Berman - GlobeNewswire
Corcept Therapeutics Class Action Reminder for Investors - Intellectia AI
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Corcept Therapeutics Incorporated to Secure Counsel ... - Bluefield Daily Telegraph
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Corcept - GlobeNewswire
Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action and April 21 Lead Plaintiff Deadline (2026-03-05) - Seeking Alpha
Why Is CORT Stock Falling Today? - Stocktwits
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Corcept Therapeutics Incorporated (CORT) - ACCESS Newswire
Corcept's Korlym Drives its 2025 Revenue Surge: What's Ahead? - Yahoo Finance
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):